Citadel Advisors LLC Has $88,000 Stake in Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN)

Citadel Advisors LLC increased its stake in shares of Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN) by 422.5% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 86,763 shares of the company’s stock after acquiring an additional 70,159 shares during the period. Citadel Advisors LLC owned 0.69% of Inspira Technologies Oxy B.H.N. worth $88,000 as of its most recent filing with the SEC.

Separately, Renaissance Technologies LLC increased its holdings in shares of Inspira Technologies Oxy B.H.N. by 142.7% during the 4th quarter. Renaissance Technologies LLC now owns 36,622 shares of the company’s stock valued at $37,000 after acquiring an additional 21,532 shares during the last quarter. 12.72% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Separately, Litchfield Hills Research assumed coverage on Inspira Technologies Oxy B.H.N. in a report on Monday, June 2nd. They set a “buy” rating on the stock.

Inspira Technologies Oxy B.H.N. Trading Up 0.6%

Shares of NASDAQ IINN opened at $0.73 on Tuesday. The business’s 50-day simple moving average is $0.58 and its 200-day simple moving average is $0.83. The company has a debt-to-equity ratio of 0.09, a current ratio of 2.23 and a quick ratio of 2.13. Inspira Technologies Oxy B.H.N. Ltd. has a 52 week low of $0.40 and a 52 week high of $2.08.

About Inspira Technologies Oxy B.H.N.

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels.